Traf2- and Nck-interacting kinase inhibitors: a patent review (2008–2024)
Sign Up to like & getrecommendations! Published in 2025 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2025.2548585
Abstract: ABSTRACT Introduction Traf2- and Nck-interacting kinase (TNIK) is a crucial player in various intracellular signaling pathways, including Wnt/β-catenin, cytoskeleton organization, and immune activation. It phosphorylates several key target genes and is widely expressed in different… read more here.
Keywords: oncology; nck interacting; 2008 2024; interacting kinase ... See more keywords
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12051258
Abstract: Background: The treatment of patients with metastatic synovial sarcoma is still challenging, and the development of new molecular therapeutics is desirable. Dysregulation of Wnt signaling has been implicated in synovial sarcoma. Traf2-and-Nck-interacting kinase (TNIK) is… read more here.
Keywords: sarcoma; tnik; nck interacting; synovial sarcoma ... See more keywords